NLD 2017
COI 1.29 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/mut (carrier)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
NLD 2015
COI 1.69 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/mut (carrier)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
BEL 2012
COI 1.94 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
|||
SWE 2010
COI 4.78 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/mut (carrier)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2022
Cause of death:
Lung cancer
also uterine inflamation & a tumor on the ovaries
|
|
||
|
|||
NLD 2014
COI 2.79 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
19/1/2021
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
19/6/2016
|
GBR 2010
COI 3.13 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
GBR 2005
COI 3.83 %
*
Breed relevant health information:
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
GBR 2003
COI 2.06 %
*
Breed relevant health information:
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2014
|
|||
FRA 2011
COI 2.31 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
DNK 2007
COI 4.56 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
||
FRA 2007
COI 2.06 %
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Lumilapsen Helinä
|
14 Nov 2014 | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
||||||||||
Amarok v.d. Peellappies
|
16 Feb 2015 | N/N (clear) | N/mut (carrier) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | |||||
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/mut (carrier)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Aliisa
|
11 Mar 2017 | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | ||||||||
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
||||||||||
Antero
|
11 Mar 2017 | |||||||||
Half siblings (sire) | ||||||||||
Dakota v.d. Peellappies
|
29 Sep 2017 | N/N (clear) | N/N (clear) | |||||||
Degenerative myelopathy (DM):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Daytona v.d. Peellappies
|
29 Sep 2017 |
2017
(0 yrs)
|
Megaesophagus | |||||||
Demon v.d. Peellappies
|
29 Sep 2017 | N/N (clear) | N/N (clear) | |||||||
Degenerative myelopathy (DM):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Durango v.d. Peellappies
|
29 Sep 2017 | N/N (clear) | N/N (clear) | |||||||
Degenerative myelopathy (DM):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Half siblings (dam) | ||||||||||
Bjarki v.d. Kruikenlappies
|
29 Jul 2018 | |||||||||
Bjorne v.d. Kruikenlappies
|
29 Jul 2018 | |||||||||
Bossu v.d. Kruikenlappies
|
29 Jul 2018 | |||||||||
Dánel v.d. Kruikenlappies
|
17 Nov 2020 | N/N (clear) | N/N (clear) | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | ||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Daphne v.d. Kruikenlappies
|
17 Nov 2020 | |||||||||
Offspring |